<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03868917</url>
  </required_header>
  <id_info>
    <org_study_id>apsj07180304</org_study_id>
    <nct_id>NCT03868917</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Approach Combined With Pressure Measurement Technique to Thoracic Paravertebral Block</brief_title>
  <official_title>Comparison of Ultrasound-guided Approach and Ultrasound-guided Approach Combined With Pressure Measurement Technique to Thoracic Paravertebral Block for Open Thoracotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeungnam University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeungnam University College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Posterolateral thoracotomies are among the most painful procedures of surgery and may cause
      severe postoperative chest pain and impaired respiratory performance. Paravertebral block
      (PVB) is an established method of administering postoperative analgesia for thoracic
      procedures. PVB blocks the somatic and sympathetic nervous systems and is placed by injecting
      a local anesthetic (LA) into the paravertebral space where the nerve and its branches are
      located after exiting the intervertebral foramen. But previous study showed 5-10% of failure
      rate in PVB using ultrasound machine. Pressure measurement during needle advancement could
      improve reliability of correct needle placement. When the needle tip reaches paravertebral
      space, there is a sudden lowering of pressures due to respiratory cycle. Therefore,
      sensitivity and specificity could be improved and correct needle placement become objective
      and reproducible when PVB using ultrasound is combined with pressure measurement during
      needle advancement.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Each participant is randomized to one of two groups.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analogue scale for pain (VAS) at 2 hour after the arrival of postanesthetic care unit (PACU)</measure>
    <time_frame>2 hour after the arrival of PACU</time_frame>
    <description>VAS score is measured at 2 hour after a patient arrives in PACU. The pain VAS is a unidimensional measure of pain intensity. The pain VAS is a continuous scale comprised of a horizontal (HVAS) line, usually 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extreme (no pain 0, maximal pain 100).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Thoracotomy</condition>
  <arm_group>
    <arm_group_label>ultrasound group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The participants have continuous thoracic paravertebral block performed using only the ultrasound approach.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pressure measurement group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants have continuous thoracic paravertebral block performed using the ultrasound-guided approach combined with pressure measurement techniqueduring needle advancement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>thoracic paravertebral block using pressure measurement technique</intervention_name>
    <description>The continuous thoracic paravertebral block using ultrasound machine is combined with pressure measurement during needle advancement.</description>
    <arm_group_label>pressure measurement group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for elective thoracotomy

          -  ASA status 1,2

        Exclusion Criteria:

          -  Inability to provide adequate informed consent

          -  Any contraindication to the placement of thoracic paravertebral catheters

          -  Unstable vertebral and transverse process fractures

          -  Any chronic painful conditions or preoperative opioid use Any chronic painful
             conditions or preoperative opioid use

          -  Coagulation abnormalities or expectation to be on therapeutic anticoagulants
             postoperatively

          -  Allergy to any of the drugs/agents used in study protocol

          -  Altered mental status or emergency surgery

          -  Comorbid conditions such as sepsis, unstable angina, congestive heart failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SANGJIN PARK, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SANGJIN PARK, MD</last_name>
    <phone>82-53-620-3366</phone>
    <email>apsj0718@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Yeungnam University hospital</name>
      <address>
        <city>Daegu</city>
        <zip>705-035</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Duckhee Lee, M.D.</last_name>
      <phone>82-53-620-3365</phone>
      <email>apsj0718@yu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Sangjin Park, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Syal K, Chandel A. Comparison of the post-operative analgesic effect of paravertebral block, pectoral nerve block and local infiltration in patients undergoing modified radical mastectomy: A randomised double-blind trial. Indian J Anaesth. 2017 Aug;61(8):643-648. doi: 10.4103/ija.IJA_81_17.</citation>
    <PMID>28890559</PMID>
  </results_reference>
  <results_reference>
    <citation>Župčić M, Graf Župčić S, Duzel V, Šimurina T, Šakić L, Fudurić J, Peršec J, Milošević M, Stanec Z, Korušić A, Barišin S. A combination of levobupivacaine and lidocaine for paravertebral block in breast cancer patients undergoing quadrantectomy causes greater hemodynamic oscillations than levobupivacaine alone. Croat Med J. 2017 Aug 31;58(4):270-280.</citation>
    <PMID>28857520</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2019</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeungnam University College of Medicine</investigator_affiliation>
    <investigator_full_name>Sangjin Park</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD sharing is needed to get permission from IRB.</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>June 25, 2020</submitted>
    <returned>July 10, 2020</returned>
    <submitted>July 13, 2020</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

